Innovation Funding Incentives – USA

Overview

The United States has one of the most developed innovation funding systems in the world. It combines federal tax incentives, large-scale sector funding, federal grant programmes and a deep private capital market.

For businesses carrying out R&D or scaling new technology, the main advantage is that there are multiple routes to support. The challenge is choosing the right one and making sure the project is documented properly.

1. Federal R&D tax incentives

The federal R&D tax credit remains the core tax incentive for innovation in the U.S. It provides a dollar-for-dollar reduction in federal tax liability and can also be used by eligible small businesses to offset part of their payroll tax liability.

In addition, U.S. businesses can again deduct domestic research and experimental costs in the year incurred. Foreign R&D remains subject to longer amortisation rules, so location of spend still matters. For clients, that is an important point because the tax outcome can differ sharply depending on whether the work is performed in the U.S. or abroad.

The credit and deduction rules are technical, so eligibility should be tested carefully. In general, the activity must involve technological uncertainty and a process of experimentation, rather than routine development or cosmetic improvement.

2. Sector funding

The federal government has also committed major funding to strategic technology sectors, particularly semiconductors and other critical technologies. These measures support manufacturing, supply chain resilience, workforce development and commercialisation.

The broader theme is clear: the U.S. is using public funding not just to reward R&D, but to strengthen domestic capacity in areas viewed as strategically important. For companies in those sectors, that can open up additional grant and investment opportunities.

3. SBIR and STTR

SBIR and STTR remain important non-dilutive funding sources for small businesses working on technical innovation. They are especially relevant for deep tech, hardware, life sciences and other science-led ventures.
Phase I funding is used to prove feasibility, while Phase II supports further development and commercialisation. The awards vary by agency, but the programmes are widely used as an early source of capital for businesses that are too early for venture funding or do not yet want dilution.

4. NSF and other grants

The National Science Foundation continues to support basic and applied research across a wide range of technology areas. Through its technology and partnerships activity, it also helps translate research into commercial outcomes.

Alongside NSF, there are many other federal and state grants that can support proof of concept, innovation, export expansion or manufacturing-related development. These programmes tend to be sector-specific, so the right route depends heavily on the business model and project type.

5. Investor and state support

The U.S. also has a very strong venture capital market, which remains a major source of growth capital for innovative companies.

That private capital is supported by state and local tax credits, grant programmes and loan incentives in many jurisdictions. This makes the U.S. attractive not just because of the tax credit regime, but because there is a full financing ecosystem around it.

Companies can often move from R&D support to grant support and then into private capital as the business scales.

6. Practical view

The U.S. is still one of the most attractive innovation markets, but it is also one of the most technical. The incentives are valuable, yet they require discipline around eligibility, documentation and timing.

For most clients, the best results come from planning early, mapping the project to the available measures and making sure the tax and grant positions are aligned from the start.

We’re here to help. Contact us to discuss how ABGi Ireland can support your global innovation strategy.